Michal Fisher

Michal Fisher has a diverse work experience spanning various industries. Currently, they serve as the Vice President of Corporate Development at LifeSci Partners, where they provide strategic healthcare advisory services. Michal joined the company in June 2020. Additionally, Michal is an Advisory Board Member at WE@HealthTech starting from January 2023. Previously, they owned their own company, Annadex Ltd., from 2017 to June 2020. Michal also worked at Neopharm Group as a BD&L from March 2018 to March 2020. Prior to that, Michal held multiple roles at SK Pharma, including Head of Strategic Alliances, Key Account Manager, and Corporate Development at TrioxBio. Michal was also the Founder and CEO of Argaman Design Products from 2010 to 2013. Starting their career, they worked at Rachshei Lev as the Head of Recreational Activity and at Hadassa Medical Center as an Associate Coordinator of the Bone Marrow Transplant Unit (National Service).

Michal Fisher earned a Bachelor of Science (B.Sc) in Biotechnology from Bar-Ilan University in 2011. Subsequently, they obtained a Master's degree (MA) in Law for Business Graduates from the same university in 2017.